首页> 外国专利> Fermentation analogs of virginiamycin M.sub.1

Fermentation analogs of virginiamycin M.sub.1

机译:维吉尼亚霉素M.sub.1的发酵类似物

摘要

Virginiamycin M.sub.1 having the Formula: ##STR1## and virginiamycin M. sub.1 analogs having the Formulae I-IV: ##STR2## Virginiamycin M.sub.1 and the analogs I-IV are antagonists of cholecystokinin (CCK) and gastrin. Cholecystokinin antagonists are useful as analgesics and in the treatment and prevention of disorders of the gastrointestinal, central nervous and appetite regulatory systems in animals, especially humans. Gastrin antagonists are useful in blocking the receptors for gastrin in humans and may function as agents for the treatment of ulcers, tumors or other gastrointestinal disorders. The compounds of Formulae I-IV are antibiotics and are useful as antimicrobial agents in animals including man and are useful as food additives to promote feed utilization in animals. Virginiamycin M.sub.1 and the analogs of Formula I, III and IV are produced by the controlled aerobic fermentation of a strain of Streptomyces olivaceus, ATCC No. 53527, while the analog of Formula II is produced by chemical synthesis.
机译:具有分子式:## STR1 ##的弗吉尼亚霉素M.sub.1和具有分子式I-IV的弗吉尼亚霉素M.sub.1类似物:## STR2 ##弗吉尼亚霉素M.sub.1和类似物I-IV是它们的拮抗剂胆囊收缩素(CCK)和胃泌素。胆囊收缩素拮抗剂可用作镇痛药,并用于治疗和预防动物尤其是人的胃肠道,中枢神经和食欲调节系统疾病。胃泌素拮抗剂可用于阻断人类胃泌素的受体,并可用作治疗溃疡,肿瘤或其他胃肠道疾病的药物。式I-IV的化合物是抗生素,并且在包括人在内的动物中用作抗微生物剂,并且用作食品添加剂以促进动物中的饲料利用。弗吉尼亚霉素M.sub.1和式I,III和IV的类似物是通过对有氧链霉菌ATCC No.53527的菌株进行有氧发酵而制得的,而式II的类似物是通过化学合成制得的。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号